| Literature DB >> 30190855 |
Maggie Hodges1, Edward Jones1, Teresa Jones1, Nathan Pearlman1, Csaba Gajdos1, Nicole Kounalakis1, Martin McCarter1.
Abstract
Little attention has been paid to the characteristics and outcomes of patients who experience distant, local or regional recurrence of melanoma following a negative sentinel lymph node biopsy. This article aims to review the published literature on the topic and presents some general summaries regarding this patient population. Patients who experience a disease recurrence following a negative sentinel lymph node biopsy have a worse overall survival compared with patients with a positive sentinel lymph node biopsy. The implications and possible explanations for these findings are discussed in order to both underscore the need for in-depth investigation of local, regional or distant melanoma recurrence among patients following a true negative sentinel lymph node biopsy, as well as increased efforts to minimize the rate of false negative sentinel lymph node biopsies.Entities:
Keywords: false-negative rate; melanoma; outcomes; recurrence; sentinel lymph node; survival
Year: 2015 PMID: 30190855 PMCID: PMC6094687 DOI: 10.2217/mmt.15.19
Source DB: PubMed Journal: Melanoma Manag ISSN: 2045-0885